Skip to content

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  225.90
+5.21 (2.36%)
AAPL  276.23
+4.74 (1.75%)
AMD  215.84
+12.06 (5.92%)
BAC  52.09
+0.52 (1.02%)
GOOG  317.61
+17.96 (5.99%)
META  615.72
+21.47 (3.61%)
MSFT  474.94
+2.82 (0.60%)
NVDA  182.21
+3.33 (1.86%)
ORCL  200.34
+1.58 (0.79%)
TSLA  420.90
+29.81 (7.62%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.